News6 months ago
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
Allogene Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of...